Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

GTPases and their Regulation

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trio and CRMP2 regulate axon branching and Semaphorin3A signaling.

Communications biology·2025

Same author

Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil.

Brain : a journal of neurology·2025

Same author

Phosphorylation of NLGN4X Regulates Spinogenesis and Synaptic Function.

eNeuro·2025

Same author

Analyses of Human Genetic Data to Identify Clinically Relevant Domains of Neuroligins.

Genes·2025

Same author

Biochemical Properties of Synaptic Proteins Are Dependent on Tissue Preparation: NMDA Receptor Solubility Is Regulated by the C-Terminal Tail.

Journal of cellular biochemistry·2024

Same author

Contrastsing synaptic roles of MDGA1 and MDGA2.

bioRxiv : the preprint server for biology·2023

Same journal

A large brain adds new types of neurons: Molecular and functional signatures of spindle neurons in the human neocortex.

Trends in neurosciences·2026

Same journal

Exercise as a regulator of glymphatic function.

Trends in neurosciences·2026

Same journal

The neural basis of laughter.

Trends in neurosciences·2026

Same journal

Enteric neuroimmune interactions in health and disease.

Trends in neurosciences·2026

Same journal

Atomic insights into the physiological and functional diversity of NMDA receptors.

Trends in neurosciences·2026

Same journal

Cognitive functions of the GPe.

Trends in neurosciences·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 5, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Modeling human mutations to understand TRIO GEF function during development.

Erin Fingleton¹, Katherine W Roche²

¹Receptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Graduate Partnership Program, Neuroscience Department, Brown University, Providence, RI, USA.

Trends in Neurosciences

|March 23, 2023

Summary

This summary is machine-generated.

Researchers investigated the Trio protein

Keywords:

Rac1 alphafold autism axon outgrowth de novo mutations

More Related Videos

Microinjection of Zebrafish Embryos to Analyze Gene Function

Microinjection of Zebrafish Embryos to Analyze Gene Function

Published on: March 9, 2009

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: Aug 5, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Microinjection of Zebrafish Embryos to Analyze Gene Function

Microinjection of Zebrafish Embryos to Analyze Gene Function

Published on: March 9, 2009

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Area of Science:

Molecular biology
Neuroscience
Genetics

Background:

Trio is a guanine nucleotide exchange factor (GEF) that activates Rac1.
Trio's GEF domain plays a crucial role in cellular processes.
Dysregulation of Trio's function is implicated in various diseases.

Purpose of the Study:

To elucidate the molecular regulation of Trio's Rac1-GEF domain.
To understand Trio's role in axon guidance.
To explore the mechanisms of Trio GEF regulation in health and disease.

Main Methods:

In silico structure prediction of the Trio Rac1-GEF domain.
Analysis of human genetic data.
Investigated Trio's function in axon guidance.

Main Results:

The study provides insights into the molecular structure of the Trio Rac1-GEF domain.
Identified key regulatory mechanisms of Trio's GEF activity.
Highlighted the role of Trio in axon guidance.

Conclusions:

Bonnet and colleagues' study advances the understanding of Trio's molecular regulation.
The findings offer potential therapeutic targets for diseases involving Trio dysregulation.
This research deepens the knowledge of axon guidance mechanisms.